PMC:7455778 / 18933-19735 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T33","span":{"begin":272,"end":278},"obj":"Body_part"},{"id":"T34","span":{"begin":482,"end":505},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma54437"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma45661"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":272,"end":278},"obj":"Body_part"},{"id":"T13","span":{"begin":482,"end":505},"obj":"Body_part"},{"id":"T14","span":{"begin":488,"end":505},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0001711"},{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0001557"},{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T152","span":{"begin":0,"end":14},"obj":"Disease"},{"id":"T153","span":{"begin":18,"end":26},"obj":"Disease"},{"id":"T154","span":{"begin":38,"end":52},"obj":"Disease"},{"id":"T155","span":{"begin":386,"end":404},"obj":"Disease"},{"id":"T156","span":{"begin":395,"end":404},"obj":"Disease"},{"id":"T157","span":{"begin":488,"end":515},"obj":"Disease"},{"id":"T158","span":{"begin":506,"end":515},"obj":"Disease"},{"id":"T159","span":{"begin":727,"end":735},"obj":"Disease"}],"attributes":[{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0001466"},{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0003085"},{"id":"A157","pred":"mondo_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A159","pred":"mondo_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/MONDO_0005594"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T149","span":{"begin":375,"end":385},"obj":"http://purl.obolibrary.org/obo/CL_0000066"},{"id":"T150","span":{"begin":433,"end":441},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T151","span":{"begin":621,"end":625},"obj":"http://purl.obolibrary.org/obo/CLO_0001406"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T109","span":{"begin":0,"end":14},"obj":"Phenotype"},{"id":"T110","span":{"begin":38,"end":52},"obj":"Phenotype"},{"id":"T111","span":{"begin":175,"end":197},"obj":"Phenotype"},{"id":"T112","span":{"begin":259,"end":267},"obj":"Phenotype"},{"id":"T113","span":{"begin":292,"end":300},"obj":"Phenotype"},{"id":"T114","span":{"begin":318,"end":327},"obj":"Phenotype"},{"id":"T115","span":{"begin":329,"end":355},"obj":"Phenotype"},{"id":"T116","span":{"begin":386,"end":404},"obj":"Phenotype"},{"id":"T117","span":{"begin":482,"end":515},"obj":"Phenotype"},{"id":"T118","span":{"begin":727,"end":735},"obj":"Phenotype"},{"id":"T119","span":{"begin":737,"end":749},"obj":"Phenotype"}],"attributes":[{"id":"A109","pred":"hp_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A110","pred":"hp_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A111","pred":"hp_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/HP_0030953"},{"id":"A112","pred":"hp_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/HP_0012375"},{"id":"A113","pred":"hp_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/HP_0010783"},{"id":"A114","pred":"hp_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/HP_0000967"},{"id":"A115","pred":"hp_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/HP_0011896"},{"id":"A116","pred":"hp_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/HP_0011859"},{"id":"A117","pred":"hp_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/HP_0002788"},{"id":"A118","pred":"hp_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/HP_0100699"},{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0430007"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":457,"end":466},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T7","span":{"begin":796,"end":802},"obj":"http://purl.obolibrary.org/obo/GO_0007601"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-sentences","denotations":[{"id":"T182","span":{"begin":0,"end":52},"obj":"Sentence"},{"id":"T183","span":{"begin":53,"end":72},"obj":"Sentence"},{"id":"T184","span":{"begin":73,"end":107},"obj":"Sentence"},{"id":"T185","span":{"begin":108,"end":174},"obj":"Sentence"},{"id":"T186","span":{"begin":175,"end":234},"obj":"Sentence"},{"id":"T187","span":{"begin":235,"end":258},"obj":"Sentence"},{"id":"T188","span":{"begin":259,"end":271},"obj":"Sentence"},{"id":"T189","span":{"begin":272,"end":304},"obj":"Sentence"},{"id":"T190","span":{"begin":305,"end":359},"obj":"Sentence"},{"id":"T191","span":{"begin":360,"end":374},"obj":"Sentence"},{"id":"T192","span":{"begin":375,"end":408},"obj":"Sentence"},{"id":"T193","span":{"begin":409,"end":432},"obj":"Sentence"},{"id":"T194","span":{"begin":433,"end":470},"obj":"Sentence"},{"id":"T195","span":{"begin":471,"end":519},"obj":"Sentence"},{"id":"T196","span":{"begin":520,"end":555},"obj":"Sentence"},{"id":"T197","span":{"begin":556,"end":670},"obj":"Sentence"},{"id":"T198","span":{"begin":671,"end":802},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T76","span":{"begin":472,"end":498},"obj":"UBERON:0000970"},{"id":"T93","span":{"begin":411,"end":416},"obj":"NCBITaxon:10239"},{"id":"T138","span":{"begin":170,"end":176},"obj":"UBERON:0001711"},{"id":"T139","span":{"begin":222,"end":237},"obj":"UBERON:0003893"},{"id":"T140","span":{"begin":262,"end":271},"obj":"UBERON:0000483"},{"id":"T141","span":{"begin":361,"end":384},"obj":"UBERON:0001557"},{"id":"T142","span":{"begin":583,"end":595},"obj":"UBERON:0001811"},{"id":"T143","span":{"begin":620,"end":640},"obj":"UBERON:0001772"},{"id":"T144","span":{"begin":664,"end":670},"obj":"GO:0007601"},{"id":"T145","span":{"begin":728,"end":736},"obj":"SP_7"},{"id":"T146","span":{"begin":750,"end":761},"obj":"NCBITaxon:10508"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}

{"project":"LitCovid-PubTator","denotations":[{"id":"488","span":{"begin":0,"end":14},"obj":"Disease"},{"id":"489","span":{"begin":18,"end":26},"obj":"Disease"},{"id":"490","span":{"begin":27,"end":72},"obj":"Disease"},{"id":"491","span":{"begin":272,"end":287},"obj":"Disease"},{"id":"492","span":{"begin":292,"end":300},"obj":"Disease"},{"id":"493","span":{"begin":329,"end":355},"obj":"Disease"},{"id":"494","span":{"begin":482,"end":515},"obj":"Disease"},{"id":"495","span":{"begin":751,"end":784},"obj":"Disease"}],"attributes":[{"id":"A488","pred":"tao:has_database_id","subj":"488","obj":"MESH:D003231"},{"id":"A489","pred":"tao:has_database_id","subj":"489","obj":"MESH:C000657245"},{"id":"A490","pred":"tao:has_database_id","subj":"490","obj":"MESH:D000033"},{"id":"A491","pred":"tao:has_database_id","subj":"491","obj":"MESH:D005141"},{"id":"A492","pred":"tao:has_database_id","subj":"492","obj":"MESH:D004890"},{"id":"A493","pred":"tao:has_database_id","subj":"493","obj":"MESH:D006470"},{"id":"A494","pred":"tao:has_database_id","subj":"494","obj":"MESH:D012141"},{"id":"A495","pred":"tao:has_database_id","subj":"495","obj":"MESH:C567547"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Conjunctivitis in COVID-19 Adenoviral conjunctivitis\nOnset Abrupt Abrupt\nUnilateral/bilateral Unilateral ++\nBilateral + Unilateral or bilateral (often sequentially bilateral)\nConjunctival injection Mild or very mild Varies in severity\nFollicular reaction + +\nChemosis ± ±\nEyelid swelling and erythema – ±\nConjunctival petechiae /subconjunctival hemorrhage – ±\nDischarge + ++\nEpithelial punctate keratitis – ±\nCorneal infiltrates – ±\nMembrane/pseudomembrane formation – ±\nConcurrent upper respiratory tract infection ± ±\nSymptoms Very mild-mild Mild-severe\nNatural history Self-limited within 2–4 days Self-limited within 5–14 days (could get worse during the first days)\nPotential sequelae Not Known Severe cases: conjunctival scarring, symblepharon, subepithelial corneal infiltrates, decreased vision"}